BCR ABL Quantitative RT-PCR Kit - Major

Features & Benefits

• Evaluates the molecular response up to 5 log reduction. The reporting is based on European Treatment and Outcome Study (EUTOS) guidelines and European Leukemia Net (ELN) recommendations

• The quantitation standards provided are with known copy numbers and are calibrated against WHO 1st International Genetic Reference

• Panel for the quantitation of BCR-ABL1 translocation (09/138) for assigning IS values to a measured level of BCR ABL/ABL %.

• The kit supports reverse transcription. No additional cDNA steps are required.

• High-Quality Reverse transcriptase and Taq HS in the Mastermix show Increased Inhibitor Tolerance, Thermostability, and Reproducibility.

• PCR run time: 90 Minutes

• Works with RNA extracted from Whole Blood EDTA and Bone Marrow Aspirates

• Diagnosis of Chronic Myeloid Leukemia and Ph-Positive Acute Lymphoblastic Leukemia.

• See if cancer treatment is effective. Treatment response by Log reduction (4.5 log reduction) is monitored.

• See if a patient has developed resistance to certain treatments.